论文部分内容阅读
我院从1994年元月～1999年元月,对收住院的35例肺结核患者采用抗痨化疗加胸腺肽调节免疫治疗的方法,与对照组比较效果较好,现报道如下:1 资料和方法1.1 一般资料:治疗组35例,均为符合肺结核诊断标准的住院患者,其中男27例,女8例,年龄18～50岁23例,51岁以上12例。Ⅲ型33例,其中伴空洞6例,伴咯血7例,伴肺部感染6例,Ⅳ型2例,痰菌阳性者23例。对照组40例,其中男27例,女13例,18～50岁31例,51岁以上9例。Ⅲ型1例,Ⅲ型35例,其中伴空洞12例,伴咯血9例,Ⅳ型4例。痰菌阳性者25例。1.2 治疗方法:(1)治疗组:2SHRZ/4HR,再以胸腺肽20～50mg,加入10％葡萄糖注射液250ml中静滴,滴速60～80滴/
Our hospital from January 1994 to January 1999, admitted to hospital 35 cases of tuberculosis patients with anti-tuberculosis chemotherapy and thymosin-mediated immunotherapy methods, compared with the control group is better, are reported as follows: 1 Materials and Methods 1.1 General information: The treatment group of 35 patients, all in line with the diagnostic criteria for tuberculosis inpatients, including 27 males and 8 females, aged 18 to 50 years old in 23 cases, 51 cases over 12 cases. Ⅲ type 33 cases, including 6 cases with empty hole, with hemoptysis in 7 cases, with pulmonary infection in 6 cases, type Ⅳ in 2 cases, sputum positive in 23 cases. The control group of 40 patients, including 27 males and 13 females, 18 to 50 years in 31 cases, 51 years of age in 9 cases. 1 case of type Ⅲ and 35 cases of type Ⅲ, including 12 cases with empty cavity, 9 cases with hemoptysis and 4 cases with type Ⅳ. Phlegm positive in 25 cases. 1.2 Treatment: (1) treatment group: 2SHRZ / 4HR, then thymosin 20 ~ 50mg, 10% glucose injection by adding 250ml intravenous drip, drip 60 ~ 80 drops /